Jon Frampton

1 - 10 out of 97Page size: 10

Publications

  1. 2019
  2. Published

    CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex

    Giacomo Volpe, Jon Frampton, 24 Jan 2019, In : Leukemia. 33, p. 1608-1619 12 p.

    Research output: Contribution to journal › Article

  3. 2018
  4. Published

    Fine-tuning Mybl2 is required for proper mesenchymal-to-epithelial transition during somatic reprogramming

    Carl Ward, Giacomo Volpe, Pierre Cauchy, Anetta Ptasinska, Jon Frampton & Paloma Garcia, 7 Aug 2018, In : Cell Reports. 24, 6, p. 1496-1511

    Research output: Contribution to journal › Article

  5. Published

    Inducible disruption of the c-myb gene allows allogeneic bone marrow transplantation without irradiation

    Jon Frampton, 1 Jun 2018, In : Journal of Immunological Methods. 457, p. 66-72

    Research output: Contribution to journal › Article

  6. Published

    Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research

    Sudha Sundar, Jean-Baptiste Cazier & Jon Frampton, 15 Feb 2018, In : The Lancet Oncology. 19, 2, p. e102–e112

    Research output: Contribution to journal › Article

  7. Published

    Origin-specific Adhesive Interactions of Mesenchymal Stem Cells with Platelets Influence their Behaviour After Infusion.

    Julie Rayes, Stephen Watson, Philip Newsome, Neena Kalia, Jon Frampton, Helen McGettrick & Gerard Nash, Feb 2018, In : Stem cells (Dayton, Ohio).

    Research output: Contribution to journal › Article

  8. 2017
  9. Published

    Prognostic significance of high GFI1 expression in AML of normal karyotype and its association with a FLT3-ITD signature

    Giacomo Volpe, David Grainger, Carl Ward, Pierre Cauchy, Daniel Coleman, Peter Cockerill, Paloma Garcia & Jon Frampton, 11 Sep 2017, In : Scientific Reports. 7, 11148.

    Research output: Contribution to journal › Article

  10. Published

    Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1

    Philip Newsome, Jon Frampton & 4 others, , 17 Mar 2017, In : Journal of Biological Chemistry. 292, 11, p. 4755-4763 9 p.

    Research output: Contribution to journal › Article

  11. Published

    Targeting the transcription factor Myb by small-molecule inhibitors

    Jon Frampton, 1 Mar 2017, In : Experimental Hematology. 47, p. 31-35

    Research output: Contribution to journal › Article

  12. 2016
  13. E-pub ahead of print

    Transcriptional regulation of SPROUTY 2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3

    Mary Clarke, Giacomo Volpe, Lozan Sheriff, Carl Ward, Wenbin Wei, Stephanie Dumon, Paloma Garcia & Jon Frampton, 8 Nov 2016, In : Leukemia.

    Research output: Contribution to journal › Article

  14. 2015
  15. E-pub ahead of print

    Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction

    Emilie Dasse, Jon Frampton, 2 Dec 2015, In : Blood.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...10 Next